Insight into the therapeutic aspects of 'Zeta-Chain Associated Protein Kinase 70kDa' inhibitors: A review

Cellular Signalling

Volumn 26, Issue 11, 2014, Pages 2481-2492

  Kaur, Maninder ^a   Singh, Manjinder ^a   Silakari, Om ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

Chronic lymphocytic leukemia; Spleen tyrosine kinase; T cells; Zeta Chain Associated Protein Kinase 70kDa

Indexed keywords

1,2,4 OXADIAZOLE DERIVATIVE; 4 PYRIDIN 5 YL 2 (3,4,5 TRIMETHOXYPHENYLAMINO)PYRIMIDINE DERIVATIVE; 5 BENZYLAMINOIMIDAZO[1,2 C]PYRIMIDINE 8 CARBOXAMIDE DERIVATIVE; IMIDAZO[1,2 C]PYRIMIDINE DERIVATIVE; PROTEIN KINASE ZAP 70; PROTEIN KINASE ZAP 70 INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG; ZAP70 PROTEIN, HUMAN;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CHRONIC LYMPHATIC LEUKEMIA; CRYSTAL STRUCTURE; DRUG DETERMINATION; DRUG INFORMATION; DRUG POTENCY; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEVERE COMBINED IMMUNODEFICIENCY; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE; ANIMAL; CYTOLOGY; DEFICIENCY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE;

ANIMALS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LYMPHOCYTE ACTIVATION; PROTEIN STRUCTURE, TERTIARY; SEVERE COMBINED IMMUNODEFICIENCY; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 84906070915     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2014.06.017     Document Type: Review

References (79)

1. http://www.preservearticles.com/2012031727703/what-are-the-different-types-of-t-cells.html.
2. Randolph N., Snow E.C. Curr. Opin. Immunol. 1992, 4:333-337.
3. Schoenberger S.P., Toes R.E., van der Voort E.I., Offringa R., Melief C.J. Nature 1998, 393:480-483.
4. Cantrell D. Annu. Rev. Immunol. 1996, 14:259-274.
5. Grakoui A., Bromley S.K., Sumen C., Davis M.M., Shaw A.S., Allen P.M., Dustin M.L. Science 1999, 285:221-227.
6. Judd B.A., Koretzky G.A. Rev. Immunogenet. 2000, 2:164-174.
7. Hermiston M.L., Xu Z., Majeti R., Weiss A. J. Clin. Invest. 2002, 109:9-14.
8. Chan A.C., Iwashima M., Turck C.W., Weiss A. Cell 1992, 71:649-662.
9. Clements J.L., Boerth N.J., Lee J.R., Koretzky G.A. Annu. Rev. Immunol. 1999, 17:89-108.
10. Zhang W., Sloan-Lancaster J., Kitchen J., Trible R.P., Samelson L.E. Cell 1998, 92:83-92.
11. Weiss A., Koretzky G., Schatzman R.C., Kadlecek T. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:5484-5488.
12. Macian F., Lopez-Rodriguez C., Rao A. Oncogene 2001, 20:2476-2489.
13. Bhagwat S.S. Purinergic Signal 2009, 5:107-115.
14. Patterson H., Nibbs R., McInnes I., Siebert S. Clin. Exp. Immunol. 2014, 176:1-10.
15. Fischer A., Picard C., Chemin K., Dogniaux S., le Deist F., Hivroz C. Semin. Immunopathol. 2010, 32:107-116.
16. Arpaia E., Shahar M., Dadi H., Cohen A., Roifman C.M. Cell 1994, 76:947-958.
17. Chan A.C., Kadlecek T.A., Elder M.E., Filipovich A.H., Kuo W.L., Iwashima M., Parslow T.G., Weiss A. Science 1994, 264:1599-1601.
18. Elder M.E., Lin D., Clever J., Chan A.C., Hope T.J., Weiss A., Parslow T.G. Science 1994, 264:1596-1599.
19. Kadlecek T.A., van Oers N.S., Lefrancois L., Olson S., Finlay D., Chu D.H., Connolly K., Killeen N., Weiss A. J. Immunol. 1998, 161:4688-4694.
20. Negishi I., Motoyama N., Nakayama K., Nakayama K., Senju S., Hatakeyama S., Zhang Q., Chan A.C., Loh D.Y. Nature 1995, 376:435-438.
21. Chan A.C., Irving B.A., Fraser J.D., Weiss A. Proc. Natl. Acad. Sci. 1991, 88:9166-9170.
22. Wange R.L., Samelson L.E. Immunity 1996, 5:197-205.
23. Au-Yeung B.B., Deindl S., Hsu L.Y., Palacios E.H., Levin S.E., Kuriyan J., Weiss A. Immunol. Rev. 2009, 228:41-57.
24. Gauen L.K., Zhu Y., Letourneur F., Hu Q., Bolen J.B., Matis L.A., Klausner R.D., Shaw A.S. Interactions of p59fyn and ZAP-70 with T-cell receptor activation motifs: defining the nature of a signalling motif. Mol. Cell. Biol. 1994, 14:3729-3741.
25. Ottinger E.A., Botfield M.C., Shoelson S.E. J. Biol. Chem. 1998, 273:729-735.
26. Folmer R.H., Geschwindner S., Xue Y. Biochemistry 2002, 41:14176-14184.
27. Kong G., Dalton M., Bubeck W.J., Straus D., Kurosaki T., Chan A.C. Mol. Cell. Biol. 1996, 16:5026-5035.
28. Zhao Q., Weiss A. Mol. Cell. Biol. 1996, 16:6765-6774.
29. Magnan A., Di Bartolo V., Mura A.M., Boyer C., Richelme M., Lin Y.L., Roure A., Gillet A., Arrieumerlou C., Acuto O., Malissen B., Malissen M. J. Exp. Med. 2001, 194:491-505.
30. Lupher M.L., Songyang Z., Shoelson S.E., Cantley L.C., Band H. J. Biol. Chem. 1997, 272:33140-33144.
31. Wu J., Zhao Q., Kurosaki T., Weiss A. J. Exp. Med. 1997, 185:1877-1882.
32. Salojin K.V., Zhang J., Meagher C., Delovitch T.L. J. Biol. Chem. 2000, 275:5966-5975.
33. Gelkop S., Gish G.D., Babichev Y., Pawson T., Isakov N.T. J. Immunol. 2005, 175:8123-8132.
34. Epler J.A., Liu R., Chung H., Ottoson N.C., Shimizu Y. J. Immunol. 2000, 165:4941-4949.
35. Goda S., Quale A.C., Woods M.L., Felthauser A., Shimizu Y. J. Immunol. 2004, 172:5379-5387.
36. Pelosi M., Di Bartolo V., Mounier V., Mège D., Pascussi J.M., Dufour E., Blondel A., Acuto O. J. Biol. Chem. 1999, 274:14229-14237.
37. Williams B., Irvin B.J., Sutor S.L., Chini C.C., Yacyshyn E., Bubeck Wardenburg J., Dalton M., Chan A.C., Abraham R.T. EMBO J. 1999, 18:1832-1844.
38. Di Bartolo V., Mege D., Germain V., Pelosi M., Dufour E., Michel F., Magistrelli G., Isacchi A., Acuto O. J. Biol. Chem. 1999, 274:6285-6294.
39. Chan A.C., Dalton M., Johnson R., Kong G.H., Wang T., Thoma R., Kurosaki T. EMBO J. 1995, 14:2499-2508.
40. Wange R.L., Guitian R., Isakov N., Watts J.D., Aebersold R., Samelson L.E. J. Biol. Chem. 1995, 270:18730-18733.
41. Deindl S., Kadlecek T.A., Cao X., Kuriyan J., Weiss A. Stability of an autoinhibitory interface in the structure of the tyrosine kinase ZAP-70 impacts T cell receptor response. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:20699-20704.
42. Hatada M.H., Lu X., Laird E.R., Green J., Morgenstern J.P., Lou M., Marr C.S., Phillips T.B., Ram M.K., Theriault K. Nature 1995, 377:32-38.
43. Jin L., Pluskey S., Petrella E.C., Cantin S.M., Gorga J.C., Rynkiewicz M.J., Pandey P., Strickler J.E., Babine R.E., Weaver D.T., Seidl K.J. J. Biol. Chem. 2004, 279:42818-42825.
44. Balagopalan L., Coussens N.P., Sherman E., Samelson L.E., Sommers C.L. The LAT story: a tale of cooperativity, coordination, and choreography. Cold Spring Harb. Perspect. Biol. 2010, 2:a005512.
45. Williams B.L., Irvin B.J., Sutor S.L., Chini C.C., Yacyshyn E., Bubeck Wardenburg J., Dalton M., Chan A.C., Abraham R.T. EMBO J. 1999, 18:1832-1844.
46. Kaur M., Bahia M.S., Silakari O. Inhibitors of interleukin-2 inducible T-cell kinase as potential therapeutic candidates for the treatment of various inflammatory disease conditions. Eur. J. Pharm. Sci. 2012, 47:574-588.
47. Ishiai M., Kurosaki M., Inabe K., Chan A.C., Sugamura K., Kurosaki T. J. Exp. Med. 2000, 192:847-856.
48. Wilcox H.M., Berg L.J. J. Biol. Chem. 2003, 278:37112-37121.
49. Beach D., Gonen R., Bogin Y., Reischl I.G., Yablonski D. J. Biol. Chem. 2007, 282:2937-2946.
50. Poulin B., Sekiya F., Rhee S.G. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:4276-4281.
51. Serrano C.J., Graham L., DeBell K., Rawat R., Veri M.C., Bonvini E., Rellahan B.L., Reischl I.G. J. Immunol. 2005, 174:6233-6237.
52. Lewis R.S. Annu. Rev. Immunol. 2001, 19:497-521.
53. Rao A., Luo C., Hogan P.G. Annu. Rev. Immunol. 1997, 15:707-747.
54. Karin M., Greten F.R. Nat. Rev. Immunol. 2005, 5:749-759.
55. Roose J.P., Mollenauer M., Gupta V.A., Stone J., Weiss A. Mol. Cell. Biol. 2005, 25:4426-4441.
56. Lu L.F., Rudensky A. Molecular orchestration of differentiation and function of regulatory T cells. Genes Dev. 2009, 23:1270-1282.
57. Hivroz C., Fischer A. Curr. Biol. 1994, 4:731-733.
58. Gelfand E.W., Weinberg K., Mazer B.D., Kadlecek T.A., Weiss A. J. Exp. Med. 1995, 182:1057-1065.
59. Matsuda S., Suzuki-Fujimoto T., Minowa A., Ueno H., Kata-mura K., Koyasu S. J. Biol. Chem. 1999, 274:34515-34518.
60. Noraz N., Schwarz K., Steinberg M., Dardalhon V., Rebouissou C., Hipskind R., Friedrich W., Yssel H., Bacon K., Taylor N. J. Biol. Chem. 2000, 275:15832-15838.
61. Toyabe S., Watanabe A., Harada W., Karasawa T., Uchiyama M. Immunology 2001, 103:164-171.
62. Sakaguchi N., Takahashi T., Hata H., Nomura T., Tagami T., Yamazaki S., Sakihama T., Matsutani T., Negishi I., Nakatsuru S., Sakaguchi S. Nature 2003, 426:454-460.
63. Amin S., Parker A., Mann J. Int. J. Biochem. Cell Biol. 2008, 40:1654-1658.
64. Chen L., Widhopf G., Huynh L., Rassenti L., Rai K.R., Weiss A., Kipps T.J. Blood 2002, 100:4609-4614.
65. Rosenwald A., Alizadeh A.A., Widhopf G., Simon R., Davis R.E., Yu X., Yang L., Pickeral O.K., Rassenti L.Z., Powell J., Botstein D., Byrd J.C., Grever M.R., Cheson B.D., Chiorazzi N., Wilson W.H., Kipps T.J., Brown P.O., Staudt L.M. J. Exp. Med. 2001, 194:1639-1647.
66. Moffat D., Davis P., Hutchings M., Davis J., Berg D., Batchelor M., Johnson J., O'Connell J., Martin R., Crabbe T., Delgado J., Perry M. Bioorg. Med. Chem. Lett. 1999, 9:3351-3356.
67. Hirabayashi A., Mukaiyama H., Kobayashi H., Shiohara H., Nakayama S., Ozawa M., Tsuji E., Miyazawa K., Misawa K., Ohnota H., Isaji M. Bioorg. Med. Chem. Lett. 2008, 16:9247-9260.
68. Hirabayashi A., Mukaiyama H., Kobayashi H., Shiohara H., Nakayama S., Ozawa M., Miyazawa K., Misawa K., Ohnota H., Isaji M. Bioorg. Med. Chem. 2009, 17:284-294.
69. Vu C.B., Corpuz E.G., Merry T.J., Pradeepan S.G., Bartlett C., Bohacek R.S., Botfield M.C., Eyermann C.J., Lynch B.A., MacNeil I.A., Ram M.K., van Schravendijk M.R., Violette S., Sawyer T.K. J. Med. Chem. 1999, 42:4088-4098.
70. Vu C.B., Corpuz E.G., Pradeepan S.G., Violette S., Bartlett C., Sawyer T.K. Bioorg. Med. Chem. Lett. 1999, 9:3009-3014.
71. R. Baenteli, M.C. Bernhard, P. Buehlmayer, N.G. Cooke, R. Duthaler, K. Hinterding, G. Thoma, E. Maurice Van, M. Anette Von, L. Walliser, G. Zenke, 2,4 di(hetero)-arylamino-pyrimidine derivatives as zap-70 and/or syk inhibitors. U.S. Patent 8283356B2, (2010).
72. R. Baenteli, M.C. Bernhard, P. Buehlmayer, N.G. Cooke, R. Duthaler, K. Hinterding, G. Thoma, E. Maurice Van, M. Anette Von, L. Walliser, G. Zenke, 2,4 di (hetero)-arylamino-pyrimidine derivatives as zap-70 and/or syk inhibitors. Patent WO2005026158A1, (2004).
73. R.H. Bradbury, S.E. Pearson, E.J. Pease, E.J. Williams, 2,4-Di(hetero)-arylamino-pyrimidine derivatives as ZAP-70 and/or SYK inhibitors. Patent WO2001064656 A1, (2001).
74. R. Baenteli, M.C. Bernhard, P. Buehlmayer, N.G. Cooke, R. Duthaler, K. Hinterding, G. Thoma, E. Maurice Van, M. Anette Von, L. Walliser, G. Zenke, 2,4 Di (hetero)-arylamino-pyrimidine derivatives as ZAP-70 and/or syk inhibitors. U.S. Patent 7671063B2, (2010).
75. R. Baenteli, G. Zenke, N.G. Cooke, R. Duthaler, G. Thoma, A.V. Matt, T. Honda, N. Matsuura, K. Nonomura, O. Ohmori, I. Umemura, K. Hinterding, C. Papageorgiou, 2,4-diaminopyrimidine derivatives. U.S. Patent 8431589 B2, (2013).
76. N. Ramsden, J. Major, A. Morel, M. Sunose, N. Piton, Pyrimidine derivatives as zap-70 inhibitors. Patent WO 2010142766 A3, (2011).
77. J. Major, N. Piton, Sulfamides as zap-70 inhibitors. E.P. Patent 2443095 A1, (2012).
78. J. Major, R.J. Harrison, N. Ramsden, D. Middlemiss, U. Kruse, G. Drewes, Sulfonamides as zap-70 inhibitors. Patent WO 2009112490 A1, (2009).
79. J. Major, N. Piton, Sulfonamides and sulfamides as zap-70 inhibitors. Patent WO 2010146132 A1, (2010).